Bicycle Therapeutics Plc (BCYC)
5.06
+0.16
(+3.27%)
USD |
NASDAQ |
Apr 02, 16:00
5.06
0.00 (0.00%)
After-Hours: 16:23
Bicycle Therapeutics Research and Development Expense (TTM) : 275.99M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.234M |
| Mereo BioPharma Group Plc | 17.81M |
| Autolus Therapeutics Plc | 117.80M |
| DBV Technologies SA | 107.07M |
| Cellectis SA | 75.00M |